MAT1A and hepatocellular carcinoma: Chronic hepatitis and cirrhosis and HCC of rodents and humans are characterized by a fall in MAT1A expression and a rise in MAT2A expression, with consequent decrease of MAT1A: MAT2A ratio (an event referred to as “MAT1A/MAT2A switch”) [83,85].